Physician profile
Vikrant Uberoi
NPI 1063672871
$10,805.23
in general payments reported to CMS, 2019-2025
50 companies · $1,700 in 2025
The $1,700 reported for 2025 was more than what 76% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,136 · 2020: $350 · 2021: $1,253 · 2022: $1,344 · 2023: $2,227 · 2024: $1,796 · 2025: $1,700.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,638 · Education: $85.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,638.12 |
| Education | $85.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,501.19 | 2019-2025 | Myrbetriq, Xtandi, Veozah |
| Neotract INC. | $822.35 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $706.65 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $705.13 | 2023-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $517.01 | 2019-2025 | Erleada, Akeega |
| Myriad Genetic Laboratories, INC. | $479.41 | 2021-2025 | Prolaris |
| Abbvie INC. | $469.36 | 2021-2025 | Botox, Lupron Depot |
| Pfizer INC. | $415.61 | 2019-2025 | |
| Teleflex LLC | $374.09 | 2021-2024 | Urolift |
| Endo Pharmaceuticals INC. | $361.60 | 2019-2023 | Xiaflex, Aveed, Edex |
| Progenics Pharmaceuticals, INC. | $350.92 | 2022-2025 | Pylarify |
| Dendreon Pharmaceuticals LLC | $338.24 | 2019-2025 | Provenge |
| Boston Scientific Corporation | $324.47 | 2019-2024 | Rezum Generator, Tactra, Ams 700 |
| Ferring Pharmaceuticals INC. | $293.83 | 2019-2025 | Adstiladrin |
| Merck Sharp & Dohme LLC | $250.88 | 2022-2025 | Keytruda, Lynparza, Welireg |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $247.57 | 2023-2024 | Itind System |
| Urogen Pharma, INC. | $239.70 | 2022-2025 | Jelmyto |
| Medtronic, INC. | $212.81 | 2022-2025 | Interstim |
| Allergan, INC. | $210.72 | 2019-2021 | |
| Antares Pharma, INC. | $207.06 | 2019-2025 | Xyosted |
| Myovant Sciences INC. | $184.40 | 2021-2022 | |
| Endo USA, INC. | $174.19 | 2024-2025 | Xiaflex, Aveed, Edex |
| Urovant Sciences INC | $156.59 | 2021-2022 | |
| Axonics, INC. | $150.26 | 2021-2024 | Axonics |
| Blue Earth Diagnostics | $109.61 | 2019-2023 | |
| Accord Healthcare, INC. | $107.94 | 2023-2025 | |
| Tolmar, INC. | $101.96 | 2024-2025 | Eligard, Jatenzo |
| Tolmar Pharmaceuticals, INC. | $97.60 | 2019-2021 | |
| Amgen INC. | $89.64 | 2019-2024 | Prolia, Evenity |
| Janssen Pharmaceuticals, INC | $74.24 | 2025 | Erleada |
| Bioprotect Medical, INC. | $61.37 | 2025 | Bioprotect Balloon Implant System |
| Tempus Ai, INC | $58.09 | 2024-2025 | Xt Cdx |
| Acerus Pharmaceuticals Corporation | $55.95 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $41.21 | 2025 | |
| Janssen Scientific Affairs, LLC | $39.29 | 2020 | |
| Clarus Therapeutics INC. | $34.71 | 2021 | |
| Coloplast Corp | $32.27 | 2021-2023 | Speedicath |
| 180 Medical, INC. | $27.19 | 2019 | |
| Immunitybio, INC. | $23.27 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $20.93 | 2021 | |
| Avadel Specialty Pharmaceuticals, LLC | $20.80 | 2019 | |
| Palette Life Sciences, INC. | $20.06 | 2022 | |
| Procept Biorobotics Corporation | $19.36 | 2023 | Aquabeam Robotic System |
| Alnylam Pharmaceuticals INC. | $17.20 | 2024 | Givlaari |
| Verity Pharmaceuticals INC. | $16.77 | 2025 | Trelstar |
| Abc Home Medical Supply, INC. | $15.21 | 2024 | |
| Foundation Medicine, INC. | $14.96 | 2022 | |
| Laborie Medical Technologies Corp. | $11.56 | 2025 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$361,837.72 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vikrant Uberoi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.